Skip to main content


Pronunciation: AH brill-ah-dah
Generic name: adalimumab-afzb
Dosage form: Abrilada pen (40 mg/0.8 mL), single-dose prefilled glass syringe (40 mg/0.8 mL, 20 mg/0.4 mL, 10 mg/0.2 mL), single-dose glass vial for institutional use only (40 mg/0.8 mL)
Drug class: TNF alfa inhibitors

Medically reviewed by Melisa Puckey, BPharm. Last updated on Oct 23, 2023.

What is Abrilada?

Abrilada (adalimumab-afzb) is an interchangeable biosimilar of Humira, made by Pfizer. Abrilada is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis. Abrilada is used to reduce pain, inflammation, and skin symptoms in these autoimmune conditions. Abrilada is a biologic medicine from the class of medicines called TNF alfa inhibitors (TNF blockers).

As Abrilada is an interchangeable biosimilar to Humira, it can be automatically substituted by a pharmacist for Humira, with individual state laws controlling how and whether physicians will be notified.

Pfizer received FDA approval for Abrilada on November 15, 2019, and on October 5, 2023, the FDA designated Abrilada as an interchangeable biosimilar to Humira.

How does Abrilada work?

Abrilada works by blocking tumor necrosis factor (TNF), a protein involved in causing inflammation; this helps to reduce pain, inflammation, and skin symptoms of these conditions.

Abrilada is used to treat chronic autoimmune conditions. Normally, your immune system defends your body against diseases by fighting harmful bacteria or viruses. However, in autoimmune disorders, the immune system becomes hyperactive and mistakenly attacks its own tissues, leading to symptoms of the autoimmune condition. Tumor necrosis factor is involved in causing inflammation in autoimmune disorders, so by Abrilada blocking TNF reduces the symptoms of these conditions.

What is Abrilada used for?

Abrilada is an FDA-approved medicine to be used for: 

What are biosimilars and interchangeable biosimilars?

Biosimilars are biologic medicines that are a very close copy of the original product made by another company.

An interchangeable biosimilar has undergone an additional Interchangeability Study, meaning that patients can be confident in the safety and effectiveness of the interchangeable biosimilar product, just as they would be for the FDA-approved original product. Abrilada is an interchangeable biosimilar which means it can be automatically substituted by a pharmacist for Humira, with individual state laws controlling how and whether physicians will be notified.

A reference product is the first brand of the biologic product approved by the FDA; Humira is the reference product for adalimumab.

Abrilada side effects

Common Abrilada side effects

Common side effects of Abrilada may include:

Get emergency medical help if you have any of these signs of an allergic reaction hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Serious Abrilada side effects

Call your doctor right away if you have any symptoms of lymphoma:

Also, call your doctor at once if you have:

Older adults may be more likely to develop infections or cancer while using Abrilada.

This is not a complete list of side effects, and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088


Abrilada affects your immune system. You may get infections more easily, even serious or fatal infections.

Before or during treatment with Abrilada, tell your doctor if you have signs of infection, such as fever, chills, aches, tiredness, cough, skin sores, diarrhea, or burning when you urinate.

Your doctor should test you for tuberculosis (TB) before starting to take this medicine and also monitor you closely for signs and symptoms of TB during treatment.

The chances of getting cancer may be increased for children and adults taking TNF-blockers.

Do not take Abrilada if you are allergic to the active ingredient adalimumab or to any of the inactive ingredients. 

Before taking this medicine

Before using Abrilada, tell your doctor if you have signs of infection - fever, chills, sweats, muscle aches, tiredness, cough, bloody mucus, skin sores, diarrhea, burning when you urinate, or feeling constantly tired.

Abrilada should only be used in age groups for the specific conditions it is FDA-approved to treat. Children using Abrilada should be current on all childhood immunizations before starting treatment.

Tell your doctor if you have ever had:

Tell your doctor where you live and if you have recently traveled or plan to travel. You may be exposed to infections that are common in certain areas of the world.

Abrilada may cause a rare type of lymphoma (cancer) of the liver, spleen, and bone marrow that can be fatal. This has occurred mainly in teenagers and young men with Crohn's disease or ulcerative colitis. However, anyone with an inflammatory autoimmune disorder may have a higher risk of lymphoma. Talk with your doctor about your own risk.


It is not known whether Abrilada will harm an unborn baby. Tell your doctor if you are pregnant or planning a pregnancy. Make sure any doctor caring for your newborn baby knows if you used this medicine while you were pregnant, especially before your baby receives any vaccines.


It may not be safe to breastfeed a baby while you are using Abrilada. Ask your doctor about any risks and the best way to feed your baby while on this medicine.

How should I use Abrilada?

Use Abrilada exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets. Use Abrilada exactly as directed.

Abrilada is injected under the skin (subcutaneous injection) using a prefilled pen or a prefilled syringe.

The dose schedule for Abrilada will depend on the severity and the condition that you are treating. Follow your doctor's dosing instructions very carefully.

A healthcare provider will teach you how to properly use this medicine by yourself. Do not use Abrilada if you do not fully understand the instructions for proper use. Ask your doctor or pharmacist if you have any questions.

Do not use this Abrilada f you have any signs of an infection. Call your doctor for instructions.

Prepare your injection only when you are ready to give it. Do not use Abrilada if it looks cloudy, has changed color, or has particles in it. Call your pharmacist for new medicine.

Leave the prefilled pen or prefilled syringe at room temperature for 15 to 30 minutes to allow it to warm up.  Do not warm the Prefilled Syringe using heat sources such as hot water or a microwave.

Do not shake your pen. Shaking can damage your medicine.

Choose an injection site. You may inject into the front of your thighs, and your abdomen except for the 2 in (5 cm) around the belly button (navel). Rotate the injection site each time you give an injection. Each new injection site should be at least 1 inch (3 cm) away from the injection site you used before.

Do NOT inject in skin that is red, hard, tender, damaged, bruised, or scarred, and do NOT inject through your clothes.

Abrilada affects your immune system, so you may get infections more easily, even serious or fatal infections. Your doctor will need to examine you on a regular basis.

Use a needle and syringe only once, and then place them in a puncture-proof "sharps" container. Follow state or local laws about how to dispose of this container. Keep it out of the reach of children and pets.

Dosing information

The dose and frequency of Abrilada given is dependent on age, severity, and condition treated. For more information on specific dosing schedules click the link below.

Abrilada is available as:

What happens if I miss a dose?

If you forget to take your dose, inject a dose as soon as you remember. Then, take your next dose at your regular scheduled time. This will put you back on schedule. In case you are not sure when to inject Abrilada call your doctor or pharmacist. 

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Abrilada?

Do not inject into skin that is bruised, red, tender, or hard.

Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.

Do not receive a "live" vaccine while using Abrilada. The vaccine may not work as well during this time, and may not fully protect you from disease. Live vaccines include measles, mumps, rubella (MMR), polio, rotavirus, typhoid, yellow fever, varicella (chickenpox), or zoster (shingles).

What other drugs will affect Abrilada?

Some drugs should not be used together with Abrilada. Tell your doctor about all medicines you use, and those you start or stop using during your treatment with this injection, especially:

Avoid the use of live vaccines.

This list is not complete. Other drugs may interact with Abrilada, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed.


Active ingredient: adalimumab-adbm

Inactive ingredients:  glacial acetic acid, polysorbate 80, sodium acetate trihydrate, trehalose dihydrate, and Water for Injection.

The needle cover is not made with natural rubber latex.



Manufactured by: Pfizer Inc. New York, NY 10001.

Distributed by: Pfizer Labs Division of Pfizer Inc. New York, NY 10001.

Popular FAQ

A biosimilar is a biological product that is similar to a reference biologic (usually the original product) and for which there are no clinically meaningful differences in terms of safety, purity, and potency. As an example, the biosimilar Amjevita (adalimumab-atto) was approved as the first biosimilar to Humira (adalimumab). Continue reading

You can take Humira with an antibiotic if your doctor has prescribed both of these medications for you. There may be some antibiotics that are not safe to take with Humira, so do not start taking any antibiotic without prior approval from your doctor. Continue reading

Both Cosentyx and Humira are available as subcutaneous injections (which means given under the skin) and may be used to treat certain inflammatory conditions such as plaque psoriasis, psoriatic arthritis, hidradenitis suppurativa, and ankylosing spondylitis. Cosentyx is also available as an IV injection that can be administered by a healthcare provider. After an initial loading dose, Humira is given every two weeks and Cosentyx every four weeks. Continue reading

Amjevita is not yet interchangeable with Humira, and the pharmacist must get approval from your doctor before they can substitute it for Humira. To date, the only approved interchangeable biosimilar for Humira is Cyltezo, which was granted this status by the FDA in October 2021. Cyltezo will be commercially available July 1, 2023. Continue reading

In a head-to-head clinical study between Skyrizi and Humira, researchers found that Skyrizi was better than Humira at clearing moderate-to-severe plaque psoriasis in adults. At 16 weeks, 72% of patients given Skyrizi achieved 90% clearer skin compared to 47% of patients given Humira, a statistically significant outcome. Continue reading

More FAQ

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.